NX Prenatal to Participate in the Solebury Trout 4th Annual Private Company Showcase on October 19

LOUISVILLE, Ky. and HOUSTON, Oct. 16, 2018 (GLOBE NEWSWIRE) -- NX Prenatal today announced that senior management will participate in the Solebury Trout 4th Annual Private Company Showcase. The event is attended by investors focused on private, emerging stage biotech companies and co-hosted by Davis Polk, BMO, RR Donnelley and CFGI.

Conference Details:

Event: Solebury Trout 4th Annual Private Company Showcase
Date/Time: Friday, October 19, 2018 at 1:00 pm EDT
Location: New York, NY

About NX Prenatal
NX Prenatal Inc. is a private, US-based molecular diagnostics company. The company’s proprietary NeXosome® platform is being utilized to develop enabling, early warning systems for pregnancies that may result in spontaneous preterm birth, preeclampsia and other adverse outcomes. NX Prenatal has demonstrated the clinical utility of its biomarker panels for prenatal risk assessment as early as 10 weeks gestation. This technology exploits biologically active and stable microparticles, such as exosomes, from the maternal bloodstream, to provide a real-time and non-invasive view of changing maternal and fetal cells and tissues. For more information, please visit the company's website at www.nxprenatal.com

About Solebury Trout

For more than 20 years, Solebury Trout has partnered with private and public companies in the life sciences industry, helping management teams prepare for capital raising, access investors and tackle complex investor relations and corporate communications issues. With more than 70 dedicated professionals, Solebury Trout team members have expertise in investor relations, equity research, investment banking, corporate communications and media relations. Solebury Trout is affiliated with leading equity capital markets advisory firm Solebury Capital, which in 2017 advised on nearly 40 percent of the IPO proceeds in the U.S. Solebury Capital is owned by PNC, one of the largest diversified financial institutions in the U.S.


Brian D. Brohman
Chief Executive Officer
Phone: 502-893-4570
E-mail: info@nxprenatal.com
Internet: www.nxprenatal.com